Stocks Overview

LAST PRICE
42.5500
TODAY'S CHANGE (%)
Trending Down-0.0400 (-0.0939%)

Bid / Lots
42.4000/ 5
Ask / Lots
42.6600/ 1
Open / Previous Close
42.7900 / 42.5900
Day Range
Low 42.5400
High 42.7900
52 Week Range
Low 19.5900
High 43.5898
Volume
912,342
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 42.59
Time	Volume	CERE
09:32 ET	2093	42.71
09:34 ET	2660	42.69
09:36 ET	3483	42.64
09:38 ET	2900	42.59
09:39 ET	5750	42.565
09:41 ET	2700	42.595
09:43 ET	3100	42.595
09:45 ET	3391	42.64
09:48 ET	1100	42.64
09:50 ET	700	42.62
09:52 ET	3257	42.65
09:54 ET	300	42.625
09:56 ET	1600	42.6
09:57 ET	2100	42.595
09:59 ET	700	42.61
10:01 ET	15531	42.595
10:03 ET	1853	42.595
10:06 ET	2902	42.605
10:08 ET	2614	42.59
10:10 ET	1500	42.605
10:12 ET	1100	42.6
10:15 ET	900	42.6
10:17 ET	900	42.6
10:19 ET	1999	42.635
10:21 ET	1395	42.61
10:24 ET	500	42.6
10:26 ET	2300	42.595
10:28 ET	500	42.605
10:30 ET	3500	42.62
10:32 ET	788	42.614
10:33 ET	51569	42.605
10:35 ET	1333	42.61
10:37 ET	12141	42.69
10:39 ET	1480	42.665
10:42 ET	200	42.665
10:44 ET	1982	42.67
10:46 ET	100	42.67
10:48 ET	927	42.67
10:50 ET	100	42.68
10:51 ET	600	42.68
10:53 ET	700	42.68
10:55 ET	100	42.685
10:57 ET	500	42.685
11:00 ET	800	42.685
11:02 ET	300	42.685
11:04 ET	400	42.69
11:06 ET	366	42.685
11:08 ET	3495	42.66
11:09 ET	1326	42.655
11:11 ET	300	42.66
11:13 ET	600	42.66
11:15 ET	1929	42.64
11:18 ET	200	42.645
11:20 ET	419	42.63
11:22 ET	500	42.635
11:24 ET	300	42.635
11:26 ET	2300	42.6225
11:27 ET	1200	42.63
11:29 ET	500	42.635
11:31 ET	1100	42.625
11:33 ET	59364	42.6125
11:36 ET	3900	42.605
11:38 ET	5900	42.625
11:40 ET	800	42.63
11:42 ET	1506	42.64
11:44 ET	800	42.685
11:45 ET	3260	42.65
11:47 ET	4898	42.625
11:49 ET	2300	42.6225
11:51 ET	1500	42.62
11:54 ET	1000	42.63
11:56 ET	4000	42.62
11:58 ET	1200	42.595
12:00 ET	62300	42.615
12:02 ET	4035	42.6
12:03 ET	3065	42.595
12:05 ET	3800	42.595
12:07 ET	2560	42.595
12:09 ET	1900	42.6
12:12 ET	1600	42.6
12:14 ET	2900	42.6
12:16 ET	702	42.6
12:18 ET	1233	42.595
12:20 ET	2700	42.595
12:21 ET	1900	42.595
12:23 ET	943	42.6
12:25 ET	17187	42.595
12:27 ET	700	42.595
12:30 ET	700	42.5969
12:32 ET	1900	42.595
12:34 ET	200	42.6
12:36 ET	214	42.6
12:38 ET	400	42.595
12:39 ET	386	42.6
12:41 ET	700	42.6
12:43 ET	5360	42.5994
12:45 ET	1000	42.595
12:48 ET	880	42.59
12:50 ET	100	42.595
12:52 ET	200	42.595
12:54 ET	400	42.595
12:56 ET	300	42.595
12:57 ET	1799	42.6
12:59 ET	12800	42.605
01:01 ET	4067	42.605
01:03 ET	6114	42.6
01:06 ET	100	42.605
01:08 ET	2150	42.595
01:10 ET	1400	42.595
01:12 ET	200	42.595
01:14 ET	100	42.6
01:15 ET	1200	42.59
01:17 ET	62166	42.615
01:19 ET	2846	42.615
01:21 ET	100	42.61
01:24 ET	400	42.61
01:26 ET	700	42.6
01:28 ET	2444	42.605
01:30 ET	200	42.6
01:32 ET	700	42.605
01:33 ET	3600	42.595
01:37 ET	400	42.595
01:39 ET	100	42.595
01:42 ET	4816	42.605
01:44 ET	1588	42.595
01:46 ET	1362	42.595
01:48 ET	1200	42.6
01:50 ET	700	42.59
01:51 ET	300	42.595
01:53 ET	100	42.595
01:55 ET	200	42.595
01:57 ET	513	42.595
02:00 ET	1100	42.595
02:02 ET	400	42.6
02:04 ET	1008	42.595
02:06 ET	731	42.6
02:08 ET	2328	42.6
02:09 ET	18513	42.65
02:11 ET	300	42.63
02:13 ET	400	42.625
02:15 ET	2300	42.625
02:18 ET	4480	42.65
02:20 ET	2759	42.665
02:22 ET	400	42.665
02:24 ET	853	42.68
02:26 ET	300	42.69
02:27 ET	100	42.685
02:29 ET	615	42.685
02:31 ET	1070	42.67
02:33 ET	3106	42.67
02:36 ET	4153	42.655
02:38 ET	100	42.655
02:40 ET	1000	42.65
02:42 ET	956	42.635
02:44 ET	1015	42.61
02:45 ET	2768	42.595
02:47 ET	2134	42.605
02:49 ET	1800	42.605
02:51 ET	100	42.605
02:54 ET	400	42.605
02:56 ET	1992	42.605
02:58 ET	380	42.605
03:00 ET	609	42.605
03:02 ET	8424	42.605
03:03 ET	1400	42.605
03:05 ET	1200	42.6
03:07 ET	2000	42.605
03:09 ET	100	42.605
03:12 ET	500	42.605
03:14 ET	1619	42.6
03:16 ET	1032	42.595
03:18 ET	700	42.595
03:20 ET	300	42.595
03:21 ET	1694	42.595
03:23 ET	200	42.595
03:25 ET	100	42.5925
03:27 ET	536	42.6
03:30 ET	300	42.59
03:32 ET	300	42.6
03:34 ET	400	42.6
03:36 ET	378	42.6
03:38 ET	900	42.6
03:39 ET	1163	42.595
03:41 ET	400	42.595
03:43 ET	5602	42.595
03:45 ET	2370	42.595
03:48 ET	9439	42.565
03:50 ET	2999	42.545
03:52 ET	3017	42.56
03:54 ET	5807	42.56
03:56 ET	8570	42.6
03:57 ET	10527	42.59
03:59 ET	185402	42.55

Data delayed at least 15 minutes.

Apr 30, 2024
- CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) Buyout and Encourages Investors to Contact the Firm, from 8:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
  8:00AM ET on Tuesday Apr 30, 2024 by Dow Jones
Apr 18, 2024
- DJ AbbVie's Bet on a Neuroscience Drug Maker Just Got Better -- Heard on the Street -- WSJ, from 12:17PM ET on Thursday Apr 18, 2024 by Dow Jones
  12:17PM ET on Thursday Apr 18, 2024 by Dow Jones
- Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease, from 6:30AM ET on Thursday Apr 18, 2024 by Dow Jones
  6:30AM ET on Thursday Apr 18, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCERE Cerevel Therapeutics Holdings Inc	7.7B	-16.0x	---
United StatesVKTX Viking Therapeutics Inc	8.4B	-82.7x	---
United StatesPCVX Vaxcyte Inc	7.0B	-16.2x	---
United StatesCYTK Cytokinetics Inc	6.7B	-12.0x	---
United StatesRVMD Revolution Medicines Inc	6.7B	-10.7x	---
United StatesIBRX Immunitybio Inc	6.0B	-8.1x	---
As of 2024-05-03

Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including schizophrenia, Alzheimer’s disease psychosis, epilepsy, panic disorder and Parkinson’s disease. Its pipeline candidates include Emraclidine, Darigabat, Tavapadon and CVL-871. Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype (M4). Darigabat is a PAM that selectively targets the alpha 2/3/5 subunits of the GABAA receptor. Tavapadon is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of Parkinson’s disease.

Contact Information

Headquarters: 222 Jacobs Street, Suite 200CAMBRIDGE, MA, United States 02141
Phone: 212-284-2300
Fax: 302-636-5454

Executives

Chairperson of the Board of Directors: N. Coles
President, Chief Executive Officer, Member of the Board: Ronald Renaud
Chief Financial Officer: Susan Altschuller
Chief Human Resources Officer: Kenneth Dipietro
Senior Vice President - Finance, Chief Accounting Officer: Mark Bodenrader

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$7.7B
Revenue (TTM)	$0.00
Shares Outstanding	181.6M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.47
EPS	$-2.66
Book Value	$3.71
P/E Ratio	-16.0x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Cerevel Therapeutics Holdings Inc
NASDAQ:CEREUnited States

Search Criteria

Charts

Recent News

Apr 30, 2024

CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings, Inc. (CERE) Buyout and Encourages Investors to Contact the Firm, from 8:00AM ET on Tuesday Apr 30, 2024 by Dow Jones

Apr 18, 2024

DJ AbbVie's Bet on a Neuroscience Drug Maker Just Got Better -- Heard on the Street -- WSJ, from 12:17PM ET on Thursday Apr 18, 2024 by Dow Jones

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease, from 6:30AM ET on Thursday Apr 18, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar